Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Nov 1, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc.
| -182.15K |
—
|
—
| -27.84% | 472.06K |
Nov 1
| |||||||
Apellis Pharmaceuticals, Inc.
| -37.00K |
$36.23 | -$1,340,596.80 | -27.01% | 100K |
Sep 16
| |||||||
Apellis Pharmaceuticals, Inc.
| -192.00 |
$36.21 | -$6,951.55 | -0.50% | 38.14K |
Sep 16
| |||||||
Apellis Pharmaceuticals, Inc.
| -550.00 |
$39.49 | -$21,720.05 | -1.41% | 38.33K |
Sep 3
| |||||||
Apellis Pharmaceuticals, Inc.
| 5.2K |
$13.85 | $72,033.85 | +9.42% | 60.4K |
Aug 12
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| 900 |
$13.19 | $11,871.00 | +0.67% | 134.42K |
Jun 28
| |||||||
Apellis Pharmaceuticals, Inc.
| -37.00K |
$39.24 | -$1,451,834.95 | -21.26% | 137K |
Jun 21
| |||||||
Apellis Pharmaceuticals, Inc.
| 24.5K |
$3.76 | $92,120.00 | +2.20% | 1.14M |
May 20
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$23.33 | -$3,001,758.84 |
—
| 1.12M |
May 8
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
| 149.57K |
Apr 18
| |||||||
Apellis Pharmaceuticals, Inc.
| 1.5K |
$13.19 | $19,785.00 | +1.14% | 133.52K |
Apr 12
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$28.97 | -$3,483,762.90 |
—
| 1.12M |
Apr 8
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$34.35 | -$194,520.00 |
—
| 93.34K |
Apr 1
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -18.68K |
$57.18 | -$1,068,160.90 | -9.70% | 174K |
Mar 19
| |||||||
Apellis Pharmaceuticals, Inc.
| -9.91K |
$56.90 | -$564,049.70 | -15.34% | 54.69K |
Mar 18
| |||||||
Apellis Pharmaceuticals, Inc.
| -184.00 |
$56.46 | -$10,388.82 | -0.47% | 38.88K |
Mar 15
| |||||||
Apellis Pharmaceuticals, Inc.
| -11.22K |
$57.56 | -$645,837.62 | -16.62% | 56.29K |
Mar 13
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$32.93 | -$4,043,926.49 |
—
| 1.12M |
Mar 8
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| 3.76K |
$13.85 | $52,103.70 | +3.64% | 107.15K |
Mar 6
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$34.16 | -$14,978,705.81 |
—
| 313.66K |
Mar 1
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$36.63 | -$319,160.00 |
—
| 93.34K |
Mar 1
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -781.00 |
$67.77 | -$52,925.95 | -0.75% | 103.39K |
Feb 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.15K |
$67.77 | -$77,796.40 | -1.23% | 92.45K |
Feb 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.43K |
$67.77 | -$96,974.43 | -1.51% | 93.34K |
Feb 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -3.96K |
$67.77 | -$268,492.46 | -1.25% | 313.66K |
Feb 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.15K |
$67.77 | -$77,796.40 | -0.10% | 1.12M |
Feb 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -597.00 |
$67.77 | -$40,456.84 | -0.92% | 64.61K |
Feb 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -906.00 |
$64.14 | -$58,109.21 | -0.86% | 104.17K |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -906.00 |
$64.14 | -$58,109.21 | -0.96% | 93.6K |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -906.00 |
$64.14 | -$58,109.21 | -0.95% | 94.77K |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -835.00 |
$64.14 | -$53,555.40 | -1.22% | 67.51K |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.25K |
$65.12 | -$81,401.71 | -2.62% | 46.39K |
Jan 29 - Jan 30
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -2.84K |
$64.14 | -$182,344.90 | -0.89% | 317.62K |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.25K |
$65.22 | -$81,524.19 | -2.14% | 57.21K |
Jan 29 - Jan 30
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -874.00 |
$64.14 | -$56,056.79 | -0.08% | 1.12M |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -367.00 |
$64.14 | -$23,538.72 | -0.56% | 65.2K |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -4.29K |
$63.69 | -$272,975.34 | -8.25% | 47.64K |
Jan 23
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -7.38K |
$63.69 | -$469,904.82 | -11.21% | 58.46K |
Jan 23
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -13.43K |
$65.00 | -$872,961.28 | -4.02% | 320.47K |
Jan 22
| |||||||
Apellis Pharmaceuticals, Inc.
| -4.18K |
$65.00 | -$271,943.26 | -3.83% | 105.08K |
Jan 22
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.